DLA Piper's Life Sciences Regulatory team, led by Marco de Morpurgo, recently produced a Q&A guide to life sciences regulation in the EU for Thomson Reuters. 

This Q&A provides a high-level overview of key practical issues, including life sciences clinical trials, manufacturing, marketing, abridged procedure, pharmacovigilance, data privacy, packaging and labelling, biological
medicines, medical devices, health care IT, combination products, borderlines, and natural health products.

The full article can be accessed here